Intelligent Bio Solutions (INBS) EBIT (2019 - 2024)
Intelligent Bio Solutions has reported EBIT over the past 6 years, most recently at -$3.0 million for Q1 2024.
- Quarterly results put EBIT at -$3.0 million for Q1 2024, up 54.86% from a year ago — trailing twelve months through Mar 2024 was -$10.2 million (up 15.08% YoY), and the annual figure for FY2024 was -$10.3 million, up 18.36%.
- EBIT for Q1 2024 was -$3.0 million at Intelligent Bio Solutions, down from -$2.0 million in the prior quarter.
- Over the last five years, EBIT for INBS hit a ceiling of -$28824.0 in Q1 2020 and a floor of -$6.5 million in Q1 2023.
- Median EBIT over the past 5 years was -$2.0 million (2023), compared with a mean of -$2.0 million.
- Biggest five-year swings in EBIT: tumbled 10795.49% in 2021 and later surged 57.24% in 2022.
- Intelligent Bio Solutions' EBIT stood at -$917326.0 in 2020, then tumbled by 277.91% to -$3.5 million in 2021, then surged by 38.53% to -$2.1 million in 2022, then rose by 6.55% to -$2.0 million in 2023, then crashed by 48.33% to -$3.0 million in 2024.
- The last three reported values for EBIT were -$3.0 million (Q1 2024), -$2.0 million (Q4 2023), and -$2.5 million (Q3 2023) per Business Quant data.